Track the latest Cyclerion Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Cyclerion Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Nov 25, 2024 | Slate Path Capital LPGerald David Greenspan | 10% OWNER | -357.88K | $1.55 | -$555.11K | SELL | -100.00% | 0.00 | Nov 21 | View |
Aug 11, 2023 | TERRANCE MCGUIRE | DIRECTOR | -8.00 | $3.40 | -$27.16 | SELL | -1.43% | 552.00 | Aug 09 | View |
Jun 07, 2021 | TERRANCE MCGUIRE | DIRECTOR | 96.15K | $3.12 | $300.00K | BUY | ∞ | 36.00K | Jun 03 | View |
Jun 07, 2021 | Peter Hecht | CHIEF EXECUTIVE OFFICER | 823.17K | $3.28 | $2.70M | BUY | 67.20% | 2.05M | Jun 03 | View |
Jun 07, 2021 | Slate Path Capital LPGerald David Greenspan | 10% OWNER | 961.54K | $3.12 | $3.00M | BUY | 15.52% | 7.16M | Jun 03 | View |
May 10, 2021 | Peter Hecht | CHIEF EXECUTIVE OFFICER | 302.00K | $2.43 | $733.86K | BUY | 32.72% | 1.23M | May 06 | View |
May 06, 2021 | Peter Hecht | CHIEF EXECUTIVE OFFICER | 698.00K | $2.43 | $1.69M | BUY | 310.21% | 923.01K | May 04 - May 05 | View |
Mar 01, 2021 | Anjeza Gjino | CHIEF FINANCIAL OFFICER | -1.82K | $4.00 | -$7.30K | SELL | -5.46% | 31.60K | Feb 25 | View |
Mar 01, 2021 | Christopher Wright | CHIEF MEDICAL OFFICER | -2.64K | $3.99 | -$10.52K | SELL | -5.81% | 42.73K | Feb 25 | View |
Dec 30, 2020 | Mark Currie | — | -20.11K | $3.01 | -$60.52K | SELL | -7.40% | 251.65K | Dec 28 | View |
Nov 12, 2020 | Andreas Busch | — | 125.00K | $2.53 | $316.25K | PURCHASE | 96.37% | 254.70K | Nov 09 | View |
Nov 10, 2020 | William Huyett | — | -3.83K | $2.52 | -$9.64K | SELL | -5.36% | 67.59K | Nov 06 | View |
Browse insider trades on all stocks.